ArticleAIDS research and human retroviruses2011

Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.

Ouzama Nicholson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.